Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;14(2):162-175.
doi: 10.20892/j.issn.2095-3941.2017.0020.

Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms

Affiliations

Immunohistochemical evaluation of vitamin D receptor (VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms

Francesco La Marra et al. Cancer Biol Med. 2017 May.

Abstract

Objective: : Vitamin D receptor (VDR) mediates vitamin D activity. We examined whether VDR expression in excised melanoma tissues is associated with VDR gene (VDR) polymorphisms.

Methods: : We evaluated VDR protein expression (by monoclonal antibody immunostaining), melanoma characteristics, and carriage of VDR-FokI-rs2228570 (C>T),VDR-BsmI-rs1544410 (G>A),VDR-ApaI-rs7975232 (T>G), andVDR-TaqI-rs731236 (T>C) polymorphisms (by restriction fragment length polymorphism). Absence or presence of restriction site was denoted by a capital or lower letter, respectively: " F" and " f" for FokI, " B" and " b" for BsmI, " A" and " a" for ApaI, and " T" and " t" for TaqI endonuclease. Seventy-four Italian cutaneous primary melanomas (52.1±12.7 years old) were studied; 51.4% were stage I, 21.6% stage II, 13.5% stage III, and 13.5% stage IV melanomas. VDR expression was categorized as follows: 100% positivevs. <100%; over the median 20% (high VDR expression) vs. ≤20% (low VDR expression); absence vs. presence of VDR-expressing cells.

Results: : Stage I melanomas, Breslow thickness of <1.00 mm, level II Clark invasion, Aa heterozygous genotype, and AaTT combined genotype were more frequent in melanomas with high vs. low VDR expression. Combined genotypes BbAA, bbAa, AATt, BbAATt, and bbAaTT were more frequent in 100% vs. <100% VDR-expressing cells. Combined genotype AATT was more frequent in melanomas lacking VDR expression (odds ratio=14.5; P=0.025). VDR expression was not associated with metastasis, ulceration, mitosis >1, regression, tumor-infiltrating lymphocytes, tumoral infiltration of vascular tissues, additional skin and non-skin cancers, and melanoma familiarity.

Conclusions: : We highlighted that VDR polymorphisms can affect VDR expression in excised melanoma cells. Low VDR expression in AATT carriers is a new finding that merits further study. VDR expression possibly poses implications for vitamin D supplementation against melanoma. VDR expression and VDR genotype may become precise medicinal tools for melanoma in the future.

Keywords: FokI polymorphism; VDR polymorphism; VDR protein expression; Vitamin D receptor; cutaneous melanoma; metastatic melanoma; predictive biomarkers; skin cancer.

PubMed Disclaimer

Figures

1
1
Representative image of VDR protein expression in cutaneous melanoma tissue. Melanoma showing diffuse positivity for VDR expression. Eroded epidermis (H&E staining, 25×. Bar indicates 50 μm).
2
2
Representative image of VDR protein expression in cutaneous melanoma tissue. Melanoma featuring tumor-infiltrating lymphocytes (TILs). Intraepidermal component of lesion (at the bottom of image) shows strong positivity for VDR expression (H&E staining, 25×. Bar indicates 50 μm).
3
3
Representative image of VDR protein expression in cutaneous melanoma tissue. Melanoma featuring TILs. In this case, melanoma cells nesting in the dermis are negative throughout the whole lesion (H&E staining, 25×. Bar indicates 50 μm).

Similar articles

Cited by

References

    1. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. International Agency for Research on Cancer (IARC). Available at: http://globocan.iarc.fr/Default.aspx; accessed March 27, 2017.

    1. Arnold M, Holterhues C, Hollestein LM, Coebergh JWW, Nijsten T, Pukkala E, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol. 2014;28:1170–8. - PubMed
    1. EUCAN. Malignant melanoma of skin. Available at: http://eu-cancer.iarc.fr/EUCAN/Cancer.aspx?Cancer=20; accessed March 27, 2017.

    1. Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:743–800. - PMC - PubMed
    1. ITACAN. AIRTUM. The Italian Association of Cancer Registries. I numeri del cancro in Italia - 2016. Available at: htttp://www.registri-tumori.it/itacan; accessed March 27, 2017.

LinkOut - more resources